Anaptysbio (ANAB) Accounts Payables (2016 - 2026)
Anaptysbio's Accounts Payables came in at $7.52 million for Q1 2026, up 22.8% from $6.12 million a year earlier and up 94.2% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Accounts Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, Anaptysbio's Accounts Payables was $3.87 million, down 3.3% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $4 million in FY2024 (-14.8%), $4.7 million in FY2023 (+68.8%), $2.78 million in FY2022 (+59.9%) and $1.74 million in FY2021 (-58.7%).
- The Q1 2026 figure represents the highest quarterly Accounts Payables since Q1 2020.
- Year-over-year, Accounts Payables increased in three of the last eight quarters, with an average decline of 6.9%.
- The fastest year-over-year change in Accounts Payables over five years came in Q2 2023 (growth of 200.0%), and the weakest in Q2 2022 (a decline of 61.3%).
- Business Quant data shows ANAB's Accounts Payables at $3.87 million (Q4 2025), $2.89 million (Q3 2025) and $3.33 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Anaptysbio | 1.46 Bn | 346.34 Mn | - | 7.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7.52 Mn |
| Dec 31, 2025 | 3.87 Mn |
| Sep 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Jun 30, 2024 | 4.89 Mn |
| Mar 31, 2024 | 4.58 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Sep 30, 2023 | 6.52 Mn |
| Jun 30, 2023 | 4.76 Mn |
| Mar 31, 2023 | 3.17 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Sep 30, 2022 | 3.01 Mn |
| Jun 30, 2022 | 1.59 Mn |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 1.74 Mn |
| Sep 30, 2021 | 5.72 Mn |
| Jun 30, 2021 | 4.10 Mn |
API Access
Anaptysbio Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();